Information regarding the Coronavirus (COVID-19)

Due to the COVID-19 pandemic, we are taking the following precautions to protect our patients, staff, and providers.


We are following all federal and state guidelines for offering procedures in our center. Our Endoscopy Center is open for procedures.

Patients scheduled in our center are referred for a COVID-19 test 3-5 days prior to their appointment.

For procedure appointments, we ask that you limit the number of accompanying adults to one; they may not remain in the waiting room during your procedure. All patients and visitors (and our employees) are required to wear a facemask to enter the center. Everyone will be screened upon arrival. Anyone experiencing any COVID-19 symptoms will not be allowed to enter.

Clinic visits:

We are offering in-person office visits at both our Eastside and Westside offices. We also continue to offer video visits, allowing our patients to get the care they need safely from home. Patients need to have access to a device with a camera and microphone. You do not need to download anything, you can see the instructions for video visits here. To schedule a video visit, please call our scheduling department at 503-229-1883.

Our Infusion Center remains open.

If you are scheduled for an in-person appointment and you are experiencing symptoms like a fever, cough, and shortness of breath we ask that you reschedule your appointment.

Calling the office:

Our phone hours are 8:00am-5:00pm, Monday-Friday. We appreciate your patience when calling the office as we have limited staffing and people working remotely to accommodate social distancing. You may need to leave a message for a return call. If you have a MyHealth account, we recommend using the portal to send a message to receive a faster response. 

To learn more about COVID-19, or to find the latest information:

Coronavirus (COVID-19) Vaccine Information 

Is the COVID-19 vaccine right for me?

The physicians of Northwest Gastroenterology have been carefully reviewing information related to the FDA EUA approved Pfizer and Moderna vaccines. Both vaccines completed all three phases of clinical trials and were determined to be safe and effective. We recognize patients with inflammatory bowel disease, autoimmune hepatitis, and those taking immunosuppressive medications were not represented in these trials. Data will not be available for these populations for some time. However, it appears the risk of contracting COVID-19 is higher than the risks associated with the vaccines. The current vaccines do not contain live virus and cannot cause infection.  It is unlikely the vaccine will induce a flare of autoimmune disease but this is not certain.

We recommend all patients including those with inflammatory bowel disease and those taking immunosuppressive medications consider vaccination. Please discuss any concerns you may have regarding anaphylactic reaction with your primary care physician. If you are receiving corticosteroid therapy you may wish to discuss timing of your vaccination due to concern for decreased efficacy of the vaccine while on steroid therapy.

We do not have access to COVID-19 vaccines at this time.